Paper 1: The EUROCAT network - organization and processes

PA Boyd, M Haeusler, I Barisic, Maria Loane, E Garne, Helen Dolk

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population-based congenital anomaly registries in Europe, funded by the European Union, which has been in operation for more than 30 years. It currently surveys more than 1.7 million births per year, including 31% of births in the European Union, and includes almost all population-based European congenital anomaly registries as its members. EUROCAT member registries collect data, ascertained from multiple sources, on all major structural congenital and chromosomal anomalies. EUROCAT surveillance relates to three areas: prevalence, primary prevention, and prenatal screening. This article describes the history of EUROCAT and gives an overview of the current methodology and work of EUROCAT covering the database content and management, coding and classification of anomalies, core surveillance, prevalence tables, statistical monitoring. The monitoring of new developments in prenatal diagnosis, medication during pregnancy, use of folic acid, and investigation of clusters and exposures are overseen by working groups responsible for organizing research and producing regular reports. The EUROCAT Web site includes current data on prevalence rates and prenatal detection rates-an example of information useful to clinicians, public health service managers, and patients.
LanguageEnglish
PagesS2-S15
JournalBirth Defects Research (Part A): Clinical & Molecular Teratology
Volume91
DOIs
Publication statusPublished - 2011

Fingerprint

Registries
Organizations
European Union
Prenatal Diagnosis
Parturition
United States Public Health Service
Primary Prevention
Folic Acid
Population
History
Databases
Pregnancy
Research
Surveys and Questionnaires

Cite this

@article{07a89408946045f7ba5a0654ceb1c6b7,
title = "Paper 1: The EUROCAT network - organization and processes",
abstract = "The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population-based congenital anomaly registries in Europe, funded by the European Union, which has been in operation for more than 30 years. It currently surveys more than 1.7 million births per year, including 31{\%} of births in the European Union, and includes almost all population-based European congenital anomaly registries as its members. EUROCAT member registries collect data, ascertained from multiple sources, on all major structural congenital and chromosomal anomalies. EUROCAT surveillance relates to three areas: prevalence, primary prevention, and prenatal screening. This article describes the history of EUROCAT and gives an overview of the current methodology and work of EUROCAT covering the database content and management, coding and classification of anomalies, core surveillance, prevalence tables, statistical monitoring. The monitoring of new developments in prenatal diagnosis, medication during pregnancy, use of folic acid, and investigation of clusters and exposures are overseen by working groups responsible for organizing research and producing regular reports. The EUROCAT Web site includes current data on prevalence rates and prenatal detection rates-an example of information useful to clinicians, public health service managers, and patients.",
author = "PA Boyd and M Haeusler and I Barisic and Maria Loane and E Garne and Helen Dolk",
year = "2011",
doi = "10.1002/bdra.20780",
language = "English",
volume = "91",
pages = "S2--S15",
journal = "Birth Defects Research Part A: Clinical and Molecular Teratology",
issn = "1542-0752",

}

Paper 1: The EUROCAT network - organization and processes. / Boyd, PA; Haeusler, M; Barisic, I; Loane, Maria; Garne, E; Dolk, Helen.

In: Birth Defects Research (Part A): Clinical & Molecular Teratology, Vol. 91, 2011, p. S2-S15.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Paper 1: The EUROCAT network - organization and processes

AU - Boyd, PA

AU - Haeusler, M

AU - Barisic, I

AU - Loane, Maria

AU - Garne, E

AU - Dolk, Helen

PY - 2011

Y1 - 2011

N2 - The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population-based congenital anomaly registries in Europe, funded by the European Union, which has been in operation for more than 30 years. It currently surveys more than 1.7 million births per year, including 31% of births in the European Union, and includes almost all population-based European congenital anomaly registries as its members. EUROCAT member registries collect data, ascertained from multiple sources, on all major structural congenital and chromosomal anomalies. EUROCAT surveillance relates to three areas: prevalence, primary prevention, and prenatal screening. This article describes the history of EUROCAT and gives an overview of the current methodology and work of EUROCAT covering the database content and management, coding and classification of anomalies, core surveillance, prevalence tables, statistical monitoring. The monitoring of new developments in prenatal diagnosis, medication during pregnancy, use of folic acid, and investigation of clusters and exposures are overseen by working groups responsible for organizing research and producing regular reports. The EUROCAT Web site includes current data on prevalence rates and prenatal detection rates-an example of information useful to clinicians, public health service managers, and patients.

AB - The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population-based congenital anomaly registries in Europe, funded by the European Union, which has been in operation for more than 30 years. It currently surveys more than 1.7 million births per year, including 31% of births in the European Union, and includes almost all population-based European congenital anomaly registries as its members. EUROCAT member registries collect data, ascertained from multiple sources, on all major structural congenital and chromosomal anomalies. EUROCAT surveillance relates to three areas: prevalence, primary prevention, and prenatal screening. This article describes the history of EUROCAT and gives an overview of the current methodology and work of EUROCAT covering the database content and management, coding and classification of anomalies, core surveillance, prevalence tables, statistical monitoring. The monitoring of new developments in prenatal diagnosis, medication during pregnancy, use of folic acid, and investigation of clusters and exposures are overseen by working groups responsible for organizing research and producing regular reports. The EUROCAT Web site includes current data on prevalence rates and prenatal detection rates-an example of information useful to clinicians, public health service managers, and patients.

U2 - 10.1002/bdra.20780

DO - 10.1002/bdra.20780

M3 - Article

VL - 91

SP - S2-S15

JO - Birth Defects Research Part A: Clinical and Molecular Teratology

T2 - Birth Defects Research Part A: Clinical and Molecular Teratology

JF - Birth Defects Research Part A: Clinical and Molecular Teratology

SN - 1542-0752

ER -